biotech
Alkermes' narcolepsy Phase 3 success; Boehringer's antibody deal
Endpoints News
May 12, 2026 · 18s listen
Listen · Endpoints News
Alkermes' narcolepsy Phase 3 success; Boehringer's antibody deal
0:00-0:18
Live · Kokoro-82M
Audio pre-rendered by Storyflo · cached + delivered from the edge